Fast forward to today, the longevity industry has the backing of venture capital funds, celebrity investors and pharmaceutical companies. We see three major problems with the longevity industry that are a cause for concern. Profit before evidenceInnovation is central to the longevity industry, attracting an influx of Silicon Valley investors seeking to “hack” the ageing process. The longevity industry pitches itself as a disruptive alternative to mainstream health care. But there’s no clear evidence many of the exhaustive tests and treatments the longevity industry promotes improve long-term outcomes for otherwise healthy people.